相关实验视频
Updated: Jun 12, 2025
07:58
Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
8.8K
在甲基胺诱导的急性损伤中MARK4的作用
Jin Tang1, Guoqian Hu2, Liang Zeng2
1Department of Urology, Third Xiangya Hospital, Central South University, Changsha 410013. ajin530@139.com.
概括
甲基胺 (METH) 通过增加微管亲和调节激酶4 (MARK4) 表达,导致急性损伤 (AKI). 抑制MARK4可以减少METH诱导的AKI和细胞亡.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 分子生物学分子生物学
- 毒理学 毒理学 毒理学
背景情况:
- 甲基胺 (METH) 是一种强烈的非法药物,已知会导致多器官损伤,特别影响泌尿系统.
- 急性损伤 (AKI) 是与METH滥用相关的重大临床问题.
- 微管类亲和调节酶4 (MARK4) 已成为细胞应激反应的潜在因素.
研究的目的:
- 调查MARK4在METH诱导的AKI病变发生中的作用.
- 阐明METH诱导的损伤背后的分子机制.
- 评估针对METH诱导的AKI中MARK4的治疗潜力.
主要方法:
- 建立一种METH诱导的AKI小鼠模型和一种METH毒性细胞模型 (BUMPT细胞).
- 蛋白质组分析以确定脏组织中差异表达的蛋白质.
- 使用西式涂抹对蛋白质表达的验证.
- 在体外实验涉及METH处理细胞中MARK4抑制的实验.
主要成果:
- 蛋白质组分析显示,在METH诱导的AKI脏组织中,有17种不同表达的蛋白质.
- 在接受METH治疗的小鼠脏中,MARK4和分裂的caspase-3表达显著升高.
- 抑制MARK4减弱了METH诱导的BUMPT细胞损伤,减少了分裂的caspase-3表达,并降低了亡.
结论:
- 在METH诱导的AKI中,MARK4是上调的.
- 通过调节细胞亡,METH诱导的AKI中介的MARK4起着至关重要的作用.
- 向MARK4为METH诱导的损伤提供了一个潜在的治疗策略.
更多相关视频
09:02A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
4.4K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
351
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
61
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
61
01:27Dialysis
276
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
276
01:11Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68